DGAP-News: STADA: Successful placement of a corporate bond in the amount of Euro 350 million
(firmenpresse) - DGAP-News: STADA Arzneimittel AG / Key word(s): Bond
STADA: Successful placement of a corporate bond in the amount of Euro
350 million
29.05.2013 / 15:56
---------------------------------------------------------------------
Bad Vilbel, May 29, 2013 - Today, on May 29, 2013, STADA Arzneimittel AG
has successfully placed a corporate bond with a fixed interest rate and a
volume in the amount of Euro 350 million.
The bond has a term of five years with an annual interest rate of 2.25
percent. The issue price amounts to 99.417 percent. The denomination is
Euro 1,000. The bond will be admitted to trading on the regulated market of
the Luxembourg Stock Exchange. The identification numbers are: German
Securities Code (WKN): A1TNEC, ISIN: XS0938218400, Common Code: 093821840.
The order book for the emission was oversubscribed by more than three
times.
The bond was placed both with institutional investors and private investors
in more than seven countries.
The joint lead managers for this transaction are Commerzbank
Aktiengesellschaft, Deutsche Bank AG (London Branch), DZ BANK AG Deutsche
Zentral-Genossenschaftsbank (Frankfurt am Main) and Landesbank
Hessen-Thüringen Girozentrale.
STADA intends to use the proceeds from the issue for general financing
purposes.
In addition to a corporate bond successfully issued back in 2010 (see the
Company's corporate news of April 14, 2010), STADA now has a second bond on
the capital markets which contributes to the optimization of financing
costs.
Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 / 61118
Bad Vilbel - Germany / Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101
603-506 / E-Mail: communications(at)stada.de
Or visit us in the Internet at www.stada.com.
For information regarding the securities mentioned in this corporate news,
please refer to the respective securities prospectus dated May 24, 2013,
published on the internet site of the Luxembourg Stock Exchange
(www.bourse.lu). Nothing in this corporate news constitutes an offer of
securities, an invitation to subscribe to or purchase securities, any
advice or other service in relation to the securities, nor does the
information contained herein qualify as the basis for a contractual or
other obligation. In particular, the securities referred to in this
corporate news may not be offered within the United States of America or to
persons residing in the United States of America or to those who count as
US Persons in the sense of Regulation S of the U.S. Securities Act of 1933.
The securities have not been, and will not be, registered according to the
U.S. Securities Act. The information contained in this corporate news is
not intended for distribution to or within the United States of America.
End of Corporate News
---------------------------------------------------------------------
29.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AGStadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications(at)stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime
Standard); Freiverkehr in Berlin, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
213776 29.05.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.05.2013 - 15:56 Uhr
Sprache: Deutsch
News-ID 264446
Anzahl Zeichen: 6005
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 338 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: STADA: Successful placement of a corporate bond in the amount of Euro 350 million"
steht unter der journalistisch-redaktionellen Verantwortung von
STADA Arzneimittel AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
